Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis

Journal of Experimental Medicine

Volumn 197, Issue 10, 2003, Pages 1385-1390

  Annels, Nicola E ^a   Da Costa, Cristiana E T ^a   Prins, Frans A ^a   Willemze, Annemieke ^a   Hogendoorn, Pancras C W ^a   Egeler, R Maarten ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dendritic cell; Differentiation; Inflammatory signalling; Migration; Retention

Indexed keywords

BIOCHEMICAL MARKER; CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCL11; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; BONE BIOPSY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EOSINOPHIL; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LANGERHANS CELL; LYMPH NODE BIOPSY; PARACRINE SIGNALING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD1; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CHEMOKINES, CC; CHEMOKINES, CXC; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LANGERHANS CELLS; MACROPHAGE INFLAMMATORY PROTEINS; MICE; RABBITS; RECEPTORS, CHEMOKINE;

EID: 0038190802     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030137     Document Type: Article

References (27)

1. Broadbent, V., R.M. Egeler, and M.E. Nesbit, Jr. 1994. Langerhans cell histiocytosis - clinical and epidemiological aspects. Br. J. Cancer. 70(Suppl. 23):S11-S16.
2. Egeler, R.M., and G.J. D'Angio. 1995. Medical progress: Langerhans cell histiocytosis. J. Pediatr. 127:1-11.
3. Egeler, R.M., B.E. Favara, M. van Meurs, J.D. Laman, and E. Claassen. 1999. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment. Blood. 94:4195-4201.
4. Greaves, D.R., W. Wang, D.J. Dairaghi, M.C. Dieu, B. Saint-Vis, K. Franz-Bacon, D. Rossi, C. Caux, T. McClanahan, S. Gordon, et al. 1997. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells. J. Exp. Med. 186:837-844.
5. Dieu, M.C., B. Vanbervliet, A. Vicari, J.M. Bridon, E. Oldham, S. Ait-Yahia, F. Briere, A. Zlotnik, S. Lebecque, and C. Caux. 1998. Selective recruitment for immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:373-386.
6. Sozzani, S., P. Allavena, G. D'Amico, W. Luini, G. Bianchi, M. Kataura, T. Imai, O. Yoshie, R. Bonecchi, and A. Mantovani. 1998. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161:1083-1086.
7. Delgado, E., V. Finkel, M. Baggiolini, C.R. Mackay, R.M. Steinman, and A. Granelli-Piperno. 1998. Mature dendritic cells respond to SDF-1, but not to several beta-chemokines. Immunobiology. 198:490-500.
8. Yanagihara, S., E. Komura, J. Nagafune, H. Watarai, and Y. Yamaguchi. 1998. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 161:3096-3102.
9. Gunn, M.D., K. Tangemann, C. Tam, J.G. Cyster, S.D. Rosen, and L.T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naïve T lymphocytes. Proc. Natl. Acad. Sci. USA. 95:258-263.
10. Ngo, V.N., H.L. Tang, and J.G. Cyster. 1998. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naïve T cells and activated B cells. J. Exp. Med. 188:181-191.
11. Vulcano, M., C. Albanesi, A. Stoppacciaro, R. Bagnati, G. D'Amico, S. Struyf, P. Transidico, R. Bonecchi, A. Del Prete, P. Allavena, et al. 2001. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur. J. Immunol. 31:812-822.
12. Sallusto, F., B. Palermo, D. Lenig, M. Miettinen, S. Matikainen, I. Julkunen, R. Forster, R. Burgstahler, M. Lipp, and A. Lanzavecchia. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29:1617-1625.
13. Vissers, J.L.M., F.C. Hartgers, E. Lindhout, M.B.M Teunissen, C.G. Figdor, and G.J. Adema. 2001. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J. Leukoc. Biol. 69:785-793.
14. Emile, J.F., S. Fraitag, M. Leborgne, Y. de Prost, and N. Brousse. 1994. Langerhans cell histiocytosis cells are activated Langerhans cells. J. Pathol. 174:71-76.
15. Yu, R.C., M. Alaibac, and A.C. Chu. 1995. Functional defect in cells involved in Langerhans cell histiocytosis. Arch. Dermatol. Res. 287:627-631.
16. Geissmann, F., Y. Lepelletier, S. Fraitag, J. Valladeau, C. Bodemer, M. Debre, M. Leborgne, S. Saeland, and N. Brousse. 2001. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood. 97:1241-1248.
17. Kimber, I., K. Cumberbatch, R.J. Dearman, M. Bhushan, and C.E.M. Criffiths. 2000. Cytokines and chemokines in the initiation and regulation of epidermal langerhans cell mobilization. Br. J. Dermatol. 142:401-412.
18. Caux, C., S. Ait-Yahia, K. Chemin, O. de Bouteiller, M.C. Dieu-Nosjean, B. Homey, C. Massacrier, B. Vanbervliet, A. Zlotnik, and A. Vicari. 2000. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22:345-369.
19. Kleeff, J., T. Kusama, D.L. Rossi, T. Ishiwata, H. Maruyama, H. Friess, M.W. Buchler, A. Zlotnik, and M. Korc. 1999. Detection and localization of Mip-3α/LARC/EXODUS, a macrophage proinflammatory chemokine, and its receptor in human pancreatic cancer. Int. J. Cancer. 81:650-657.
20. Sugita, S., T. Kohno, K. Yamamoto, Y. Imaizumi, H. Nakajima, T. Ishimaru, and T. Matsuyama. 2002. Induction of macrophage-inflammatory protein-3α gene expression by TNF-dependent NF-KB activation. J. Immunol. 168:5621-5628.
21. Harant, H., S.A. Eldershaw, and I.J.D. Lindley. 2001. Human macrophage inflammatory protein-3a/CCL20/LARC/Exodus/SCYA20 is transcriptionally upregulated by tumor necrosis factor-a via a non-standard NF-KB site. FEBS Lett. 509:439-445.
22. William, C.L., L. Busque, B.B. Griffith, B.E. Favara, K.L. McClain, M.H. Duncan, and D.G. Gilliland. 1994. Langerhans-cell histiocytosis (histiocytosis X)- a clonal proliferative disease. N. Engl. J. Med. 331:154-160.
23. Yu, R.C., C. Chu, L. Buluwela, and A.C. Chu. 1994. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet. 343:767-768.
24. Schouten, B., R.M. Egeler, P.J.M. Leenen, A.H.M. Taminiau, L. vd Broek, and P.C.W. Hogendoorn. 2002. Expression of cell cycle-related gene products in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 24:727-732.
25. Favara, B.E., and R. Jaffe. 1994. The Histopathology of Langerhans Cell Histiocytosis. Br. J. Cancer. 70(Suppl. 23): S17-S23.
26. Egeler, R.M., B.E. Favara, J.D. Laman, and E. Claassen. 2000. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions. Eur. J. Cancer. 36:2105-2110.
27. Liao, F., R.L. Rabin, C.S. Smith, G. Sharma, T.B. Nutman, and J.M. Farber. 1999. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J. Immunol. 162:186-194.